[go: up one dir, main page]

NO885221D0 - ESTERS OF PHARMACOLOGICALLY ACTIVE CARBOXYLIC ACIDS. - Google Patents

ESTERS OF PHARMACOLOGICALLY ACTIVE CARBOXYLIC ACIDS.

Info

Publication number
NO885221D0
NO885221D0 NO885221A NO885221A NO885221D0 NO 885221 D0 NO885221 D0 NO 885221D0 NO 885221 A NO885221 A NO 885221A NO 885221 A NO885221 A NO 885221A NO 885221 D0 NO885221 D0 NO 885221D0
Authority
NO
Norway
Prior art keywords
esters
carboxylic acids
pharmacologically active
active carboxylic
pharmacologically
Prior art date
Application number
NO885221A
Other languages
Norwegian (no)
Other versions
NO885221L (en
Inventor
Andre Furlenmeier
Marc Montavon
Christian Hubschwerlen
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO885221D0 publication Critical patent/NO885221D0/en
Publication of NO885221L publication Critical patent/NO885221L/en
Priority to NO921057A priority Critical patent/NO921057D0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation
    • C07D477/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C07D477/08—Modification of a carboxyl group directly attached in position 2, e.g. esterification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO88885221A 1987-11-24 1988-11-23 ESTERS OF PHARMACOLOGICALLY ACTIVE CARBOXYLIC ACIDS. NO885221L (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO921057A NO921057D0 (en) 1987-11-24 1992-03-18 7-AMINOCEFALOSPORINDERIVATER

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH457087 1987-11-24
CH316588 1988-08-25

Publications (2)

Publication Number Publication Date
NO885221D0 true NO885221D0 (en) 1988-11-23
NO885221L NO885221L (en) 1989-05-25

Family

ID=25692354

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88885221A NO885221L (en) 1987-11-24 1988-11-23 ESTERS OF PHARMACOLOGICALLY ACTIVE CARBOXYLIC ACIDS.

Country Status (14)

Country Link
EP (1) EP0318767A3 (en)
JP (1) JPH01165585A (en)
KR (1) KR890008082A (en)
AU (1) AU614793B2 (en)
DK (1) DK637888A (en)
FI (1) FI885330A (en)
HU (1) HU207522B (en)
IL (1) IL88403A0 (en)
MC (1) MC1991A1 (en)
NO (1) NO885221L (en)
NZ (1) NZ226989A (en)
PT (1) PT89080B (en)
SU (1) SU1598880A3 (en)
YU (2) YU216188A (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99898A (en) * 1990-11-09 1996-10-31 Eisai Co Ltd 7-Acyl-3-substituted carbamoyloxy cephem compounds their preparation and antibacterial compositions containing them
TR199701289T2 (en) * 1995-05-03 1998-08-21 Smithkline Beecham Plc Esters of carbapenems
BR112014004716A2 (en) * 2011-08-31 2017-03-28 Mallinckrodt Llc remote assembly of targeted nanoparticles using h-phosphonate-en / y-hydrophosphonylation reactions
RS66326B1 (en) 2011-09-09 2025-01-31 Merck Sharp & Dohme Llc Ceftolozane/tazobactam for treating intrapulmonary infections
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
NZ700372A (en) 2013-03-15 2016-01-29 Merck Sharp & Dohme Ceftolozane antibiotic compositions
US20140274990A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2476087A1 (en) * 1980-02-18 1981-08-21 Roussel Uclaf NOVEL OXIMES DERIVED FROM 3-ALKYLOXY OR 3-ALKYL-THIOMETHYL 7-AMINO THIAZOLYL ACETAMIDO CEPHALOSPORANIC ACID, PROCESS FOR PREPARING THEM AND THEIR APPLICATION AS MEDICAMENTS
JPS5984889A (en) * 1982-11-05 1984-05-16 Sumitomo Chem Co Ltd Cephalosporin derivatives and their production method

Also Published As

Publication number Publication date
NZ226989A (en) 1992-05-26
YU191589A (en) 1991-02-28
DK637888A (en) 1989-05-25
PT89080B (en) 1993-04-30
KR890008082A (en) 1989-07-08
HUT48895A (en) 1989-07-28
FI885330A0 (en) 1988-11-17
NO885221L (en) 1989-05-25
AU614793B2 (en) 1991-09-12
EP0318767A3 (en) 1991-03-20
AU2578588A (en) 1989-05-25
IL88403A0 (en) 1989-06-30
MC1991A1 (en) 1989-11-30
HU207522B (en) 1993-04-28
FI885330A (en) 1989-05-25
YU216188A (en) 1990-04-30
EP0318767A2 (en) 1989-06-07
SU1598880A3 (en) 1990-10-07
DK637888D0 (en) 1988-11-15
JPH01165585A (en) 1989-06-29
PT89080A (en) 1988-12-01

Similar Documents

Publication Publication Date Title
NO162560C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE NAFTYRIDINE, QUINOLINE AND BENZOCSAZINE CARBOXYL ACIDS.
NO894888D0 (en) ESTER PREPARATION BY HYDROGENERATION OF CARBOXYLIC ACID AND ANHYDRIDES.
NO173547C (en) Analogous Procedures for the Preparation of Therapeutically Active Quinolone Carboxylic Acid Derivatives
EP0302349A3 (en) Biologically active carboxylic acid esters
NO885601L (en) EVENTLY QUATATED FAT ACID ESTERS OF OXALCYLED ALKYL-ALKYLENDIAMINES.
NO885221D0 (en) ESTERS OF PHARMACOLOGICALLY ACTIVE CARBOXYLIC ACIDS.
FI882669A (en) Process for the preparation of pharmaceutically active alpha-halogenated dicarboxylic acids
GB8719886D0 (en) Carboxylic acid esters/acids
IT7828313A0 (en) PROCEDURE FOR THE PRODUCTION OF CARBOXYLIC ACIDS AND/OR THEIR ESTERS.
NO860512L (en) CARBOXYLIC ACID ESTER DERIVATIVES OF DEGLUCOTEICOPLANIN.
NO883046L (en) PROCEDURE FOR THE PREPARATION OF CHINOLON CARBOXYL ACIDS.
DE3888588D1 (en) Phenylalkenylcarboxylic acids and their esters.
DE69207387D1 (en) Manufacture of carboxylic acid esters
NO157330C (en) ANALOGUE PROCEDURE FOR PREPARATION OF PHARMACOLOGICALLY ACTIVE 3-METHYLFLAVON-8-CARBOXYLIC ACID ESTERS.
IT8620894A0 (en) PROPENYLAMINOTHIAZOLLYCEPHALOSPORAN ACIDS CI 3-(SUBSTITUTED) AND THEIR ESTERS.
DK79688A (en) PIPERAZINE CARBOXYLIC ACIDS
NO162761C (en) PROCEDURE FOR THE PREPARATION OF AN ESTER OF A DICARBOXYLIC ACID.
NO170930C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 4-OXO-3-QUINOLINE CARBOXYL ACIDS
DE69229616D1 (en) Enzymatic resolution of alpha-tertiary carboxylic acid esters
NO880587D0 (en) BICYCLIC BAA-LAKTAM CARBOXYLIC ACIDS.
NO157414C (en) PROCEDURE FOR THE PREPARATION OF CARBOXYLIC ACIDS AND ESTERS THEREOF.
IT8221707A0 (en) PRODUCTION OF CARBOXYLIC ACIDS AND ESTERS.
NO175859C (en) Process for the preparation of quinoline carboxylic acids
ZA888616B (en) Esters of pharmacologically active carboxylic acids
NO165396C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRIDINE-5 CARBOXYLIC ACID ESTERS.